ACM Research vs Azenta
ACMR and AZTA side by side, both in special industry machinery, except metalworking. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACMR and AZTA compare
ACM Research is the larger company, worth 1.7 times as much as Azenta ($3.3B against $2.0B).
ACM Research grew revenue faster over the last twelve months (29.1% versus 4.9% for Azenta).
ACM Research keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with −20.0% at Azenta.
ACM Research scores higher on the StockData Score (14 against 8 for Azenta), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACMR | AZTA |
|---|---|---|
| Size and price | ||
| Market cap | $3.3B | $2.0B |
| Share price | $47.95 | $45.65 |
| Change, 1 year | 41.8% | 48.4% |
| Change, 5 years | 49.5% | −61.8% |
| Beta (5Y) | 1.97 | 1.33 |
| Employees | 2,513 | 3,000 |
| StockData Score | ||
| Total score | 14 (better) | 8 |
| Valuation score | 2 | 2 |
| Growth score | 3 (better) | 0 |
| Performance score | 4 (better) | 0 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 29.8× | – |
| P/S | 2.9× (better) | 3.3× |
| P/B | 1.8× | 1.3× (better) |
| EV/EBITDA | 17.6× | – |
| P/FCF | – | 202× |
| PEG | 0.92 | – |
| FCF yield | −6.0% | 0.49% (better) |
| Fair value | $44.99 | $55.23 |
| Margin of safety | −6.6% | 17.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 29.1% (better) | 4.9% |
| Revenue growth, 5Y average | 41.9% (better) | 8.9% |
| Net income growth (TTM) | −1.0% | – |
| EPS growth (TTM) | −7.5% | – |
| EPS growth, 5Y average | 35.5% | – |
| Profitability | ||
| Gross margin | 43.5% | 44.0% (better) |
| Operating margin | 14.5% (better) | −28.6% |
| Net margin | 10.2% (better) | −20.0% |
| FCF margin | −17.5% | 1.6% (better) |
| Return on equity | 7.0% (better) | −7.7% |
| Return on invested capital | 15.0% (better) | −13.2% |
| Financial health | ||
| Debt / equity | 0.18 (better) | 0.00 |
| Net debt / EBITDA | −3.25 | – |
| Interest coverage | 22.4× | – |
| Current ratio | 3.16 (better) | 2.50 |
| Altman Z-score | 3.12 | 4.49 (better) |
| Piotroski F-score | 2 | 7 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 69.7% | 115% |
| Held by insiders | 5.2% | 12.6% |
| Insider net buying, 12 months | −$50.2M | $172K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 4.5% | 14.1% |
Go deeper
- ACMR stock overview
- ACMR income statement
- ACMR valuation and score
- AZTA stock overview
- AZTA income statement
- AZTA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.